Privigen 10% vial 200ML
Ended Awarded Last action
- Contract number
- SPE2DR26FHKS2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,926
Award facts
- Contract value 100% obligated
- $27,926.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,926.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Privigen 10% Vial 200ML. The contract, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499,999,999 ceiling value extending through December 31, 2036.
DMS Pharmaceutical Group Inc. serves as a critical pharmaceutical supplier within the Department of Defense's military healthcare supply chain, leveraging its single-award prime vendor contract to deliver comprehensive pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables to military healthcare facilities worldwide. As a small business pharmaceutical wholesaler registered in the System for Award Management since 2001, the company has demonstrated substantial federal contracting activity and consistent performance across diverse therapeutic categories, positioning it as a key regional vendor within the broader $30.3 billion PPV-G GEN V acquisition strategy.
Quick answers
Who was awarded contract SPE2DR26FHKS2?
SPE2DR26FHKS2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FHKS2 worth?
The government has obligated $27,926 on SPE2DR26FHKS2.
Is contract SPE2DR26FHKS2 an order under another contract?
Yes. SPE2DR26FHKS2 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKS2 competed?
The extent of competition for SPE2DR26FHKS2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award